Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Effects of indole alkaloids from leaf of Alstonia scholaris on post-infectious cough in mice
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Effects of indole alkaloids from leaf of Alstonia scholaris on post-infectious cough in mice
Creator
Yang, Zi-Feng
Wei, Xin
Huang, Wan-Yi
Khan, Afsar
Liu, Ya-Ping
Luo, Xiao-Dong
Shang, Jian-Hua
Wang, Bei
Wang, Xin-Hua
Wang, Yi-Fen
Yuan, Zhi-Wei
Zhao, Yun-Li
Source
Elsevier; Medline; PMC
abstract
Abstract Ethnopharmacological relevance Leaf of Alstonia scholaris (L.) R. Br. (Apocynaceae), a wide used ethic-medicine in many Asia and Africa counties, has also been recorded as the common traditional Chinese medicine for treatment of illnesses in respiratory system by Dai people. Aim of the study To provide experimental data of clinical adaption of total indole alkaloids (TA) from leaf of A. scholaris for treating post-infectious cough in phase II clinical trial. Materials and methods To model post-infectious cough, all animals except control group were instilled intra-tracheal with lipopolysaccharide (LPS) (80 μg/50 µL/mouse), followed by subsequent exposure to cigarette smoke (CS) for 30 min per day for a total of 30 days. Mice were orally given TA at dose of 10, 25, 50 mg/kg, and four main alkaloids (Sch: scholaricine, Epi: 19-epischolaricine, Val: vallesamine, Pic: picrinine) once daily. Cellular infiltration was assessed in the broncho-alveolar lavage fluid (BALF). Expression of interleukin-6 (IL-6) and C-reactive protein (CRP) in the serum was determined, the superoxide dismutase (SOD) activity as well as malondialdehyde (MDA) content in the serum and homogenate were examined. Finally, histopathological examination in the lungs was assessed by H. E. staining. Results After administration of TA and four major alkaloids respectively, the symptoms of cough in mice were obviously attenuated. Total white blood cells (WBC) and neutrophils (NEU) amounts in BALF were reduced obviously and the pathological damage of lung was also attenuated. There was also significant reduction in IL-6, CRP, MDA and a marked improvement in SOD. Conclusions The efficacy of indole alkaloids against post-infectious cough (PIC) was shown in the down-regulation of inflammatory cells, cytokines, and the balance of antioxidants. What's more, the pharmacological effects of TA were better than single indole alkaloid, which might be related to the synergic effect of four major alkaloids.
has issue date
2018-05-23
(
xsd:dateTime
)
bibo:doi
10.1016/j.jep.2018.02.040
bibo:pmid
29496577
has license
els-covid
sha1sum (hex)
3fb382f0bd23aaf5f7cf648705119b6f9ad69cfa
schema:url
https://doi.org/10.1016/j.jep.2018.02.040
resource representing a document's title
Effects of indole alkaloids from leaf of Alstonia scholaris on post-infectious cough in mice
has PubMed Central identifier
PMC7126965
has PubMed identifier
29496577
schema:publication
Journal of Ethnopharmacology
resource representing a document's body
covid:3fb382f0bd23aaf5f7cf648705119b6f9ad69cfa#body_text
is
schema:about
of
named entity 'BALF'
named entity 'total'
named entity 'Mice'
named entity 'treating'
named entity 'indole'
named entity 'attenuated'
named entity 'indole'
named entity 'Materials'
named entity 'LPS'
named entity 'malondialdehyde'
named entity 'INDOLE ALKALOIDS'
named entity 'PICRININE'
named entity 'SYMPTOMS'
named entity 'COUNTIES'
named entity 'SUPEROXIDE DISMUTASE'
named entity 'EFFECT'
named entity 'BRONCHO-ALVEOLAR LAVAGE'
named entity 'ATTENUATED'
named entity 'ETHIC'
named entity 'ALKALOIDS'
named entity 'CYTOKINES'
named entity 'SINGLE'
named entity 'MARKED'
named entity 'PHASE II CLINICAL TRIAL'
named entity 'USED'
named entity 'ANTIOXIDANTS'
named entity 'PROTEIN '
named entity 'REDUCED'
named entity 'RESULTS'
named entity 'MIGHT BE'
named entity 'TREATMENT'
named entity 'RELATED'
named entity 'HOMOGENATE'
named entity 'DAYS'
named entity 'MODEL'
named entity 'EXPERIMENTAL DATA'
named entity 'WHAT'
named entity 'CONTENT'
named entity 'INDOLE ALKALOID'
named entity 'METHODS'
named entity 'POST'
named entity 'MATERIALS'
named entity 'CLINICAL'
named entity 'AIM'
named entity 'BALANCE'
named entity 'PER DAY'
named entity 'TO PROVIDE'
named entity 'GIVEN'
named entity 'INTERLEUKIN-6 '
named entity 'IL-6'
named entity 'CRP'
named entity 'INTRATRACHEAL'
named entity 'INFLAMMATORY CELLS'
named entity 'C-REACTIVE PROTEIN'
named entity 'DAMAGE'
named entity 'TREATING'
named entity 'POST'
named entity 'ALSTONIA SCHOLARIS'
named entity 'IMPROVEMENT'
named entity 'WHITE BLOOD CELLS'
named entity 'ADMINISTRATION'
named entity 'CELLULAR INFILTRATION'
named entity 'HISTOPATHOLOGICAL'
named entity 'CONTROL GROUP'
named entity 'ILLNESSES'
named entity 'COUGH'
named entity 'SUBSEQUENT'
named entity 'ASIA'
named entity 'MG%'
named entity 'PHARMACOLOGICAL'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software